Denis Favreau

Title: Denis Favreau: Innovator in Pharmaceutical Chemistry

Introduction

Denis Favreau is a notable inventor based in Saint-Hubert, Canada. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on the synthesis of complex chemical compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is a process for synthesizing substituted isoquinolines. This patent details a method for creating optionally substituted 1-chloro-4-methoxyisoquinolines, along with intermediates that are useful in this process. Another significant patent involves polymorphs of an epothilone analog. This invention provides two crystalline polymorphs, designated Form A and Form B, and outlines methods for forming these novel polymorphs, as well as their therapeutic applications and pharmaceutical dosage forms.

Career Highlights

Denis has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug synthesis and formulation.

Collaborations

Throughout his career, Denis has collaborated with esteemed colleagues such as Zhenrong Guo and John D DiMarco. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Denis Favreau's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic agents.